Micreos initiates clinical trial to evaluate endolysin-drug in atopic dermatitis

This article was originally published here

The study marks the world’s first evaluation of a pharmaceutical endolysin for topical use in humans. Endolysins are highly specific enzymes that cut the bacterial cell wall, rapidly

The post Micreos initiates clinical trial to evaluate endolysin-drug in atopic dermatitis appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply